| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4093268
Max Phase: Preclinical
Molecular Formula: C16H17F3N4O2S
Molecular Weight: 386.40
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CN1C=CC(C2NC(C(F)(F)F)=CN2c2ccc(S(N)(=O)=O)cc2)C=C1
Standard InChI: InChI=1S/C16H17F3N4O2S/c1-22-8-6-11(7-9-22)15-21-14(16(17,18)19)10-23(15)12-2-4-13(5-3-12)26(20,24)25/h2-11,15,21H,1H3,(H2,20,24,25)
Standard InChI Key: HPDDWVAJCJTSJT-UHFFFAOYSA-N
Associated Targets(non-human)
Cyclooxygenase-1 1373 Activities
Cyclooxygenase-2 182 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 386.40 | Molecular Weight (Monoisotopic): 386.1024 | AlogP: 2.06 | #Rotatable Bonds: 3 |
| Polar Surface Area: 78.67 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
| #RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 10.77 | CX Basic pKa: 7.75 | CX LogP: 1.62 | CX LogD: 1.11 |
| Aromatic Rings: 1 | Heavy Atoms: 26 | QED Weighted: 0.83 | Np Likeness Score: -0.63 |
References
| 1. Zhou S, Yang S, Huang G.. (2017) Design, synthesis and bioactivities of Celecoxib analogues or derivatives., 25 (17): [PMID:28757100] [10.1016/j.bmc.2017.07.038] |
Source
Source(1):